Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
342.99
+30.79 (9.86%)
At close: May 14, 2025, 4:00 PM
351.75
+8.76 (2.55%)
After-hours: May 14, 2025, 7:33 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $4.46 billion as of May 14, 2025. Its market cap has increased by 7,522.00% in one year.
Market Cap
4.46B
Enterprise Value
4.46B
1-Year Change
7,522.00%
Ranking
Category
Stock Price
$342.99
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $4.46B, an increase of 3,616.31%. That is a compound annual growth rate of 157.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 4.06B | 6,219.84% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.64M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |